Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Proto Script Pharmaceutical's total inventories for the quarter that ended in Sep. 2017 was $0.00 Mil. Proto Script Pharmaceutical's average total inventories from the quarter that ended in Jun. 2017 to the quarter that ended in Sep. 2017 was $0.00 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Proto Script Pharmaceutical's Net-Net Working Capital per share for the quarter that ended in Sep. 2017 was $-0.03.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Proto Script Pharmaceutical's Days Inventory for the
three
months ended in Sep. 2017 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Proto Script Pharmaceutical's Inventory-to-Revenue for the quarter that ended in Sep. 2017 was 0.00.
Proto Script Pharmaceutical (OTCPK:PSCR) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Proto Script Pharmaceutical's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2017 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Proto Script Pharmaceutical's Inventory to Revenue for the quarter that ended in Sep. 2017 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Proto Script Pharmaceutical Total Inventories Related Terms
Proto Script Pharmaceutical Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proto Script Pharmaceutical Total Inventories Chart
Proto Script Pharmaceutical Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Proto Script Pharmaceutical (PSCR) has a Total Inventories of $0.00 Mil as of Sep. 2017. The total amount of inventory as recorded on a company's balance sheet. View historical data for Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Total Inventories too high?
Proto Script Pharmaceutical's current Total Inventories is $0.00 Mil.
How does Proto Script Pharmaceutical's Total Inventories compare to EXCC and NXES?
Proto Script Pharmaceutical's Total Inventories of $0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Business Services company?
A good Total Inventories depends on the Business Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Total Inventories is $0.00 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PSCR has been successfully added to your 
